Center for Scientific Review; Notice of Closed Meetings, 24036-24038 [2011-10297]
Download as PDF
<![CDATA[
srobinson on DSKHWCL6B1PROD with NOTICES
24036
Federal Register / Vol. 76, No. 83 / Friday, April 29, 2011 / Notices
provide an update on the current
process and to gather additional input
on such a program.
Date and Time: The public meeting
will be held on May 10, 2011, from 2
p.m. to 3:30 p.m.
Location: The public meeting will be
held at FDA’s White Oak Campus,
10903 New Hampshire Ave., Bldg. 1,
Conference Rooms 4101, 4103, and
4105, Silver Spring, MD 20993–0002.
Contact Person: Mari Long, Center for
Drug Evaluation and Research, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 32, rm. 4237,
Silver Spring, MD 20993–0002, 301–
796–7574, Fax 301–847–3541,
mari.long@fda.hhs.gov; or
Peter C. Beckerman, Office of Policy,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 32, rm.
4238, Silver Spring, MD 20993–0002,
301–796–4830, Fax 301–847–3541,
peter.beckerman@fda.hhs.gov.
Registration and Requests for Oral
Presentations: If you wish to attend and/
or present at the meeting, please e-mail
your registration information to
GDUFA_Meeting2@fda.hhs.gov by May
3, 2011. Your e-mail should contain
complete contact information for each
attendee, including name, title,
affiliation, address, e-mail address, and
telephone number. Registration is free
and will be on a first-come, first-served
basis. Early registration is recommended
because seating is limited. FDA may
limit the number of participants from
each organization as well as the total
number of participants, based on space
limitations. Registrants will receive
confirmation once they have been
accepted. Onsite registration on the day
of the meeting will be based on space
availability. We will try to accommodate
all persons who wish to make a
presentation. The time allotted for
presentations may depend on the
number of persons who wish to speak,
and if the entire meeting time is not
needed for presentations, FDA reserves
the right to terminate the meeting early.
If you need special accommodations
because of disability, please contact
Mari Long or Peter Beckerman (see
Contact Person) at least 7 days before
the meeting.
Comments: Regardless of attendance
at the public meeting, interested persons
may submit either electronic or written
comments regarding this document by
June 10, 2011. To ensure consideration,
all comments must be received by June
10, 2011. Submission of comments prior
to the meeting is strongly encouraged.
Submit any comments that you plan to
present at the public meeting to the
docket by the date of the public
meeting, but note that either electronic
VerDate Mar<15>2010
17:39 Apr 28, 2011
Jkt 223001
or written comments generally may be
submitted until June 10, 2011.
Submit electronic comments to
https://www.regulations.gov. Submit
written comments to the Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, rm. 1061, Rockville, MD 20852. It
is only necessary to send one set of
comments. It is no longer necessary to
send two copies of mailed comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing its intention to
hold a public meeting related to generic
drug user fees. The Agency continues to
solicit comment on whether to seek a
user fee program that would provide
additional resources for the review of
human generic drug applications, as
well as what such a program should
look like. New legislation would be
required for FDA to establish and collect
user fees for generic drugs, and FDA is
currently engaged in negotiations with
industry over aspects of a joint proposal
for a generic drug user fee program,
including fees and performance goals.
Because FDA can only negotiate with
trade organizations, not individual
companies, but remains interested in
hearing from non-affiliated companies
in addition to patient and consumer
stakeholders, the Agency will hold a
public meeting. The public meeting will
provide a status update and seek input
from stakeholders on generic drug user
fees. In addition, FDA continues to
encourage all interested stakeholders to
submit either electronic or written
comments to the docket (see
Comments).
II. What information should you know
about the public meeting, when and
where will the public meeting occur,
and what format will FDA use?
Through this notice, we are
announcing a public meeting to update
stakeholders and hear stakeholder views
on what features FDA should propose
for a generic drug user fee program. We
will conduct the meeting on May 10,
2011, from 2 p.m. to 3:30 p.m. at FDA’s
White Oak Campus, 10903 New
Hampshire Ave., Bldg. 1, Conference
Rooms 4101, 4103, and 4105, Silver
Spring, MD 20993–0002. In general, the
meeting format will include a
presentation by FDA and presentations
by stakeholders and members of the
public who have registered in advance
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
to present at the meeting. The amount
of time available for presentations will
be determined by the number of people
who register to make a presentation. We
will also provide an opportunity for
organizations and individuals to submit
either electronic or written comments to
the docket after the meeting (see
Comments). FDA policy issues are
beyond the scope of this initiative.
Accordingly, the presentations should
focus on process and funding issues,
and not focus on policy.
Dated: April 26, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–10382 Filed 4–28–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Brain
Disorders Pathology and Treatment.
Date: May 26, 2011.
Time: 11 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Dan D. Gerendasy,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7843, Bethesda, MD 20892. 301–408–
9164. gerendad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Cancer Biology and Therapeutics.
Date: June 1–2, 2011.
Time: 11 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
E:\FR\FM\29APN1.SGM
29APN1
srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 76, No. 83 / Friday, April 29, 2011 / Notices
Contact Person: Malaya Chatterjee, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892. (301) 806–
2515. chatterm@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group, Clinical Molecular
Imaging and Probe Development.
Date: June 1–2, 2011.
Time: 7 p.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Valencia Riverwalk, 150 East
Houston Street, San Antonio, TX 78205.
Eileen W. Bradley, DSC, Scientific Review
Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5100, MSC 7854, Bethesda, MD
20892. (301) 435–1179. bradleye@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group,
Musculoskeletal Tissue Engineering Study
Section.
Date: June 6–7, 2011.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jean D. Sipe, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4106,
MSC 7814, Bethesda, MD 20892. 301/435–
1743. smithbf@auburn.edu.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Somatosensory and
Chemosensory Systems Study Section.
Datea: June 7–8, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Latham Hotel, 3000 M Street, NW.,
Washington, DC 20007.
Contact Person: M. Catherine Bennett,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7846, Bethesda, MD 20892. 301–435–
1766. bennettc3@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group,
Biomedical Computing and Health
Informatics Study Section.
Date: June 7–8, 2011.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Santa Monica
Hotel, 530 West Pico Boulevard, Santa
Monica, CA 90405.
Contact Person: Melinda Jenkins, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3156,
MSC 7770, Bethesda, MD 20892. 301–437–
7872. jenkinsml2@mail.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group,
Pathobiology of Kidney Disease Study
Section.
VerDate Mar<15>2010
17:39 Apr 28, 2011
Jkt 223001
Date: June 7–8, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Fairmont San Francisco Hotel, 950
Mason Street, San Francisco, CA 94108.
Contact Person: Atul Sahai, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 2188, MSC 7818, Bethesda, MD
20892. 301–435–1198. sahaia@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Sensorimotor
Integration Study Section.
Date: June 7, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: One Washington Circle Hotel, One
Washington Circle, NW., Washington, DC
20037.
John Bishop, PhD, Scientific Review
Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5182, MSC 7844, Bethesda, MD
20892. (301) 408–9664. bishopj@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group,
Pregnancy and Neonatology Study Section.
Date: June 7, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Michael Knecht, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6176,
MSC 7892, Bethesda, MD 20892. (301) 435–
1046. knechtm@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group, Genetics
of Health and Disease Study Section.
Date: June 7–8, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Richard Panniers, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212,
MSC 7890, Bethesda, MD 20892. (301) 435–
1741. pannierr@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group,
Nursing and Related Clinical Sciences Study
Section.
Date: June 7–9, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Santa Monica
Hotel, 530 West Pico Boulevard, Santa
Monica, CA 90405.
Contact Person: Priscah Mujuru, RN,
DRPH, COHNS, Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3139, MSC 7770, Bethesda, MD 20892.
301–594–6594. mujurup@mail.nih.gov.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
24037
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group,
Dissemination and Implementation Research
in Health Study Section.
Date: June 7, 2011.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Santa Monica
Hotel, 530 West Pico Boulevard, Santa
Monica, CA 90405.
Contact Person: Jacinta Bronte-Tinkew,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
MSC 7770, Bethesda, MD 20892. (301) 806–
0009. brontetinkewjm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Collaborative Applications in Child
Psychopathology.
Date: June 7, 2011.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Washington, 1515
Rhode Island Avenue, NW., Washington, DC
20005.
Contact Person: Jane A. DoussardRoosevelt, PhD, Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892.
(301) 435–4445. doussarj@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group,
Xenobiotic and Nutrient Disposition and
Action Study Section.
Date: June 8, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sir Francis Drake Hotel, 450 Powell
Street, San Francisco, CA 94102.
Contact Person: Patricia Greenwel, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2172,
MSC 7818, Bethesda, MD 20892. 301–435–
1169. greenwep@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group,
Community Influences on Health Behavior.
Date: June 8–9, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Santa Monica
Hotel, 530 West Pico Boulevard, Santa
Monica, CA 90405.
Contact Peson: Wenchi Liang, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3150,
MSC 7770, Bethesda, MD 20892. 301–435–
0681. liangw3@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\29APN1.SGM
29APN1
24038
Federal Register / Vol. 76, No. 83 / Friday, April 29, 2011 / Notices
Dated: April 22, 2011.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–10297 Filed 4–28–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2011–0012]
Agency Information Collection
Activities: Proposed Collection;
Comment Request, 1660–NEW; Level 1
Assessment and Level III Evaluations
for the Center for Domestic
Preparedness (CDP)
Federal Emergency
Management Agency, DHS.
ACTION: Notice; 60-day notice and
request for comments; new information
collection; OMB No. 1660–NEW; FEMA
Form 092–0–2, Level 1 Assessment
Form; FEMA Form 092–0–2A, Level 3
Evaluation Form for Students; FEMA
Form 092–0–2B, Level 3 Evaluation
Form for Supervisors.
AGENCY:
The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on a proposed new
information collection. In accordance
with the Paperwork Reduction Act of
1995, this notice seeks comments
concerning course evaluations for the
Center for Domestic Preparedness.
SUMMARY:
Comments must be submitted on
or before June 28, 2011.
ADDRESSES: To avoid duplicate
submissions to the docket, please use
only one of the following means to
submit comments:
(1) Online. Submit comments at
https://www.regulations.gov under
Docket ID FEMA–2011–0012. Follow
the instructions for submitting
comments.
(2) Mail. Submit written comments to
Docket Manager, Office of Chief
Counsel, DHS/FEMA, 500 C Street, SW.,
Room 835, Washington, DC 20472–
3100.
(3) Facsimile. Submit comments to
(703) 483–2999.
(4) E-mail. Submit comments to
FEMA-POLICY@dhs.gov. Include Docket
ID FEMA–2011–0012 in the subject line.
All submissions received must
include the agency name and Docket ID.
Regardless of the method used for
submitting comments or material, all
submissions will be posted, without
change, to the Federal eRulemaking
Portal at https://www.regulations.gov,
and will include any personal
information you provide. Therefore,
submitting this information makes it
public. You may wish to read the
Privacy Act notice that is available via
the link in the footer of https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Linda S. Pressley, Assistant Director of
Analysis and Evaluation, Center for
Domestic Preparedness, 256–847–2685
for additional information. You may
contact the Records Management
Division for copies of the proposed
collection of information at facsimile
number (202) 646–3347 or e-mail
address: FEMA-Information-CollectionsManagement@dhs.gov.
DATES:
The
Center for Domestic Preparedness (CDP)
is required by Congress to identify,
develop, test, and deliver training to
State, local, and Tribal emergency
response providers, provide on-site and
mobile training at the performance and
management and planning levels, and
facilitate the delivery of training by the
training partners of the Department of
Homeland Security pursuant to Section
1204 of the Implementing
Recommendations of the 9/11
Commission Act of 2007, Public Law
110–53, 121 Stat. 266, August 3, 2007
(codified at 6 U.S.C. 1102). The
collection of this data will help facilitate
that Congressional mandate.
SUPPLEMENTARY INFORMATION:
Collection of Information
Title: Level 1 Assessment and Level
III Evaluations for the Center for
Domestic Preparedness (CDP).
Type of Information Collection: New
information collection.
OMB Number: OMB No. 1660–NEW.
Form Titles and Numbers: FEMA
Form 092–0–2, Level 1 Assessment
Form; FEMA Form 092–0–2A, Level 3
Evaluation Form for Students; FEMA
Form 092–0–2B, Level 3 Evaluation
Form for Supervisors.
Abstract: The forms in this collection
of information will be used to survey
the Center for Domestic Preparedness
(CDP) students (and their supervisors)
enrolled in CDP courses. The survey
will collect information regarding
quality of instruction, course material,
and impact of training on their
professional employment.
Affected Public: State, local or Tribal
government.
Estimated Total Annual Burden
Hours: 18,000 hours.
ANNUAL HOUR BURDEN
Number of
respondents
Data collection activity/instrument
Frequency of
responses
52,000
1
Level 1 Assessment Form, FEMA Form 092–0–2 ................
srobinson on DSKHWCL6B1PROD with NOTICES
Level 1 Assessment Form, FEMA Form 092–0–2 ................
13,000
1
Level 3 Evaluation Form for Students, FEMA Form 092–0–
2A.
Level 3 Evaluation Form for Students, FEMA Form 092–0–
2A.
Level 3 Evaluation Form for Supervisors, FEMA Form 092–
0–2B.
Level 3 Evaluation Form for Supervisors, FEMA Form 092–
0–2B.
Level 1 Assessment Form, FEMA Form 092–0–2 ................
1,500
1
2,000
1
1,500
1
2,000
1
52,000
1
Total ................................................................................
72,000
Hour burden
per response
........................
VerDate Mar<15>2010
17:39 Apr 28, 2011
Jkt 223001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
15 minutes
(.25 hours)
15 minutes
(.25 hours)
15 minutes
(.25 hours)
15 minutes
(.25 hours)
15 minutes
(.25 hours)
15 minutes
(.25 hours)
15 minutes
(.25 hours)
E:\FR\FM\29APN1.SGM
Annual
responses
Total annual
burden hours
13,000
13,000
3,250
1,500
375
2,000
500
1,500
375
2,000
500
52,000
13,000
........................
29APN1
52,000
18,000
]]>Agencies
[Federal Register Volume 76, Number 83 (Friday, April 29, 2011)]
[Notices]
[Pages 24036-24038]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-10297]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Brain Disorders Pathology and Treatment.
Date: May 26, 2011.
Time: 11 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dan D. Gerendasy, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3218, MSC 7843, Bethesda, MD 20892. 301-408-
9164. gerendad@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Cancer Biology and Therapeutics.
Date: June 1-2, 2011.
Time: 11 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting.)
[[Page 24037]]
Contact Person: Malaya Chatterjee, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD
20892. (301) 806-2515. chatterm@csr.nih.gov.
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group, Clinical Molecular Imaging
and Probe Development.
Date: June 1-2, 2011.
Time: 7 p.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Valencia Riverwalk, 150 East Houston Street, San
Antonio, TX 78205.
Eileen W. Bradley, DSC, Scientific Review Officer, Center for
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 5100, MSC 7854, Bethesda, MD 20892. (301) 435-1179.
bradleye@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group, Musculoskeletal Tissue Engineering Study
Section.
Date: June 6-7, 2011.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Jean D. Sipe, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4106, MSC 7814, Bethesda, MD 20892. 301/435-
1743. smithbf@auburn.edu.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group, Somatosensory and Chemosensory
Systems Study Section.
Datea: June 7-8, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Latham Hotel, 3000 M Street, NW., Washington, DC 20007.
Contact Person: M. Catherine Bennett, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182, MSC 7846, Bethesda, MD
20892. 301-435-1766. bennettc3@csr.nih.gov.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group, Biomedical Computing and Health Informatics
Study Section.
Date: June 7-8, 2011.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina Santa Monica Hotel, 530 West Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Melinda Jenkins, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3156, MSC 7770, Bethesda, MD 20892. 301-437-
7872. jenkinsml2@mail.nih.gov.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group, Pathobiology of Kidney Disease Study
Section.
Date: June 7-8, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Fairmont San Francisco Hotel, 950 Mason Street, San
Francisco, CA 94108.
Contact Person: Atul Sahai, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2188, MSC 7818, Bethesda, MD 20892. 301-435-
1198. sahaia@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group, Sensorimotor Integration Study
Section.
Date: June 7, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: One Washington Circle Hotel, One Washington Circle, NW.,
Washington, DC 20037.
John Bishop, PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 5182, MSC 7844, Bethesda, MD 20892. (301) 408-9664.
bishopj@csr.nih.gov.
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group, Pregnancy and
Neonatology Study Section.
Date: June 7, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael Knecht, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6176, MSC 7892, Bethesda, MD 20892. (301) 435-
1046. knechtm@csr.nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group, Genetics of Health and Disease Study Section.
Date: June 7-8, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street, NW.,
Washington, DC 20037.
Contact Person: Richard Panniers, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212, MSC 7890, Bethesda, MD
20892. (301) 435-1741. pannierr@csr.nih.gov.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group, Nursing and Related Clinical Sciences Study
Section.
Date: June 7-9, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina Santa Monica Hotel, 530 West Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Priscah Mujuru, RN, DRPH, COHNS, Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD
20892. 301-594-6594. mujurup@mail.nih.gov.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group, Dissemination and Implementation Research
in Health Study Section.
Date: June 7, 2011.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina Santa Monica Hotel, 530 West Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Jacinta Bronte-Tinkew, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164, MSC 7770, Bethesda, MD
20892. (301) 806-0009. brontetinkewjm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Collaborative Applications in Child Psychopathology.
Date: June 7, 2011.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Washington, 1515 Rhode Island Avenue,
NW., Washington, DC 20005.
Contact Person: Jane A. Doussard-Roosevelt, PhD, Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184, MSC 7848, Bethesda, MD
20892. (301) 435-4445. doussarj@csr.nih.gov.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group, Xenobiotic and Nutrient Disposition and
Action Study Section.
Date: June 8, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Sir Francis Drake Hotel, 450 Powell Street, San
Francisco, CA 94102.
Contact Person: Patricia Greenwel, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2172, MSC 7818, Bethesda, MD
20892. 301-435-1169. greenwep@csr.nih.gov.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group, Community Influences on Health Behavior.
Date: June 8-9, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina Santa Monica Hotel, 530 West Pico
Boulevard, Santa Monica, CA 90405.
Contact Peson: Wenchi Liang, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3150, MSC 7770, Bethesda, MD 20892. 301-435-
0681. liangw3@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
[[Page 24038]]
Dated: April 22, 2011.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-10297 Filed 4-28-11; 8:45 am]
BILLING CODE 4140-01-P
